Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biological and Pharmaceutical Bulletin is Scopus-indexed (Q2, CiteScore 3.1), WoS SCIE, DOAJ. Published by Pharmaceutical Society of Japan.
Checked against the index lists dated .
ISSN 0918-6158Verify ISSN ↗1347-5215Verify ISSN ↗
Publisher: Pharmaceutical Society of Japan
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 96 / 191 | 50th | Q2 |
| Pharmacology | 211 / 328 | 35th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1993–present, best quartile Q2, CiteScore 3.1.
Biological and Pharmaceutical Bulletin is Q2 in Pharmaceutical Science (rank 96 of 191) and Q3 in Pharmacology (rank 211 of 328), by CiteScore 2025.
Biological and Pharmaceutical Bulletin is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.1, which places it in quartile Q2 at the 50th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.518, quartile Q2, with an H-index of 143.
Biological and Pharmaceutical Bulletin is published by Pharmaceutical Society of Japan. Its print ISSN is 0918-6158 and its online ISSN is 1347-5215.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Biological and Pharmaceutical Bulletin has an h-index of 155 and a 2-year mean of 1.85 citations per paper (OpenAlex). Its Scopus CiteScore is 3.1, quartile Q2. On 2-year citations it ranks #85 of 177 Scopus journals in Pharmaceutical Science.
Biological and Pharmaceutical Bulletin published 250 papers in 2025; its busiest recent year was 2017 with 331. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from Japan (82.5%), China (10%) and Indonesia (2.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 22 retracted papers are recorded (1.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.